Literature DB >> 29565219

Multiple sclerosis: High prevalence of the 'central vein' sign in white matter lesions on susceptibility-weighted images.

Gianvincenzo Sparacia1, Francesco Agnello1, Angelo Gambino1, Martina Sciortino2, Massimo Midiri1.   

Abstract

Purpose The aim of this study was to determine the occurrence and distribution of the 'central vein' sign in white matter lesions on susceptibility-weighted magnetic resonance images in patients with multiple sclerosis (MS) and cerebral small vessel disease (CSVD). Materials and methods T2-weighted and fluid-attenuated inversion recovery magnetic resonance images of 19 MS patients and 19 patients affected by CSVD were analysed for the presence and localisation of focal hyperintense white matter lesions. Lesions were subdivided into periventricular or non-periventricular (juxtacortical, subcortical, deep white matter and cerebellar) distributed. The number and localisation of lesions presenting with the central vein sign were recorded and compared between MS and CSVD lesions. Results A total of 313 MS patients and 75 CSVD lesions were identified on T2-weighted and fluid-attenuated inversion recovery magnetic resonance images. The central vein sign was found in 128 MS lesions (40.9%), and the majority of them (71/128, 55.5%) had a periventricular distribution. The central vein sign was found in 22 out of 75 (29.3%) CSVD lesions, and periventricular distribution was seen in six out of 22 (27.2%) CSVD lesions. The difference in the proportion of white matter hyperintense lesions that presented with the central vein sign on susceptibility-weighted images in patients with MS and CSVD was statistically different, and a significantly higher number of MS patients presented with lesions with the central vein sign compared to CSVD patients. Conclusion The presence of the central vein sign on susceptibility-weighted images for MS lesions improves the understanding of the periventricular distribution of MS lesions and could contribute as adjunctive diagnostic criteria for MS disease.

Entities:  

Keywords:  Central vein sign; cerebral small vessel disease; magnetic resonance imaging; multiple sclerosis; susceptibility-weighted imaging

Mesh:

Year:  2018        PMID: 29565219      PMCID: PMC6111438          DOI: 10.1177/1971400918763577

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  25 in total

Review 1.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.

Authors:  Àlex Rovira; Mike P Wattjes; Mar Tintoré; Carmen Tur; Tarek A Yousry; Maria P Sormani; Nicola De Stefano; Massimo Filippi; Cristina Auger; Maria A Rocca; Frederik Barkhof; Franz Fazekas; Ludwig Kappos; Chris Polman; David Miller; Xavier Montalban
Journal:  Nat Rev Neurol       Date:  2015-07-07       Impact factor: 42.937

2.  Presence of central veins and susceptibility weighted imaging for evaluating lesions in multiple sclerosis and leukoaraiosis.

Authors:  Urška Lamot; Jernej Avsenik; Saša Šega; Katarina Šurlan Popovič
Journal:  Mult Scler Relat Disord       Date:  2017-02-14       Impact factor: 4.339

3.  The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis?

Authors:  Thomas Kau; Manuel Taschwer; Hannes Deutschmann; Martina Schönfelder; Jörg R Weber; Klaus A Hausegger
Journal:  Eur Radiol       Date:  2013-02-22       Impact factor: 5.315

4.  The topography of plaques in multiple sclerosis with special reference to cerebral plaques.

Authors:  T Fog
Journal:  Acta Neurol Scand Suppl       Date:  1965

5.  Presence of a central vein within white matter lesions on susceptibility weighted imaging: a specific finding for multiple sclerosis?

Authors:  Nina Lummel; Tobias Boeckh-Behrens; Veronika Schoepf; Michael Burke; Hartmut Brückmann; Jennifer Linn
Journal:  Neuroradiology       Date:  2010-06-29       Impact factor: 2.804

6.  The effect of venous anatomy on the morphology of multiple sclerosis lesions: a susceptibility-weighted imaging study.

Authors:  B Öztoprak; I Öztoprak; Ö K Yıldız
Journal:  Clin Radiol       Date:  2016-03-07       Impact factor: 2.350

7.  Accuracy of SWI sequences compared to T2*-weighted gradient echo sequences in the detection of cerebral cavernous malformations in the familial form.

Authors:  Gianvincenzo Sparacia; Claudia Speciale; Aurelia Banco; Francesco Bencivinni; Massimo Midiri
Journal:  Neuroradiol J       Date:  2016-08-22

8.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

9.  SWI enhances vein detection using gadolinium in multiple sclerosis.

Authors:  Pietro Maggi; Lorenzo N Mazzoni; Marco Moretti; Matteo Grammatico; Stefano Chiti; Luca Massacesi
Journal:  Acta Radiol Open       Date:  2015-03-18

10.  FLAIR* to visualize veins in white matter lesions: A new tool for the diagnosis of multiple sclerosis?

Authors:  T Campion; R J P Smith; D R Altmann; G C Brito; B P Turner; J Evanson; I C George; P Sati; D S Reich; M E Miquel; K Schmierer
Journal:  Eur Radiol       Date:  2017-04-13       Impact factor: 5.315

View more
  8 in total

1.  Gadolinium-Enhanced Susceptibility-Weighted Imaging in Multiple Sclerosis: Optimizing the Recognition of Active Plaques for Different MR Imaging Sequences.

Authors:  L L F do Amaral; D C Fragoso; R H Nunes; I A Littig; A J da Rocha
Journal:  AJNR Am J Neuroradiol       Date:  2019-03-07       Impact factor: 3.825

2.  The Central Vein Sign in Radiologically Isolated Syndrome.

Authors:  S Suthiphosuwan; P Sati; M Guenette; X Montalban; D S Reich; A Bharatha; J Oh
Journal:  AJNR Am J Neuroradiol       Date:  2019-04-18       Impact factor: 3.825

3.  Developmental venous anomalies in patients with multiple sclerosis: is that a coincidence or an ancillary finding?

Authors:  Irene Grazzini; Benedetta Calchetti; Gian Luca Cuneo
Journal:  Neurol Sci       Date:  2020-10-21       Impact factor: 3.307

4.  Multiple sclerosis: prevalence of the 'central vein' sign in white matter lesions on gadolinium-enhanced susceptibility-weighted images.

Authors:  Gianvincenzo Sparacia; Francesco Agnello; Alberto Iaia; Aurelia Banco; Massimo Galia; Massimo Midiri
Journal:  Neuroradiol J       Date:  2021-04-19

5.  Hyperhomocysteinemia and Endothelial Dysfunction in Multiple Sclerosis.

Authors:  Ekaterina Dubchenko; Alexander Ivanov; Natalia Spirina; Nina Smirnova; Mikhail Melnikov; Alexey Boyko; Evgeniy Gusev; Aslan Kubatiev
Journal:  Brain Sci       Date:  2020-09-16

6.  Investigation of Deep-Learning-Driven Identification of Multiple Sclerosis Patients Based on Susceptibility-Weighted Images Using Relevance Analysis.

Authors:  Alina Lopatina; Stefan Ropele; Renat Sibgatulin; Jürgen R Reichenbach; Daniel Güllmar
Journal:  Front Neurosci       Date:  2020-12-18       Impact factor: 4.677

7.  Sensitivity and Specificity of Central Vein Sign as a Diagnostic Biomarker in Egyptian Patients with Multiple Sclerosis.

Authors:  Hend Abdel Ghany; Ahmed Karam-Allah; Ramy Edward; Maged Abdel Naseer; Mohamed I Hegazy
Journal:  Neuropsychiatr Dis Treat       Date:  2022-09-01       Impact factor: 2.989

8.  The "Central Vein Sign" on T2*-weighted Images as a Diagnostic Tool in Multiple Sclerosis: A Systematic Review and Meta-analysis using Individual Patient Data.

Authors:  Chong Hyun Suh; Sang Joon Kim; Seung Chai Jung; Choong Gon Choi; Ho Sung Kim
Journal:  Sci Rep       Date:  2019-12-03       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.